Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)
46.57
-0.33 (-0.70%)
At close: Jan 23, 2026
SHA:603102 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | 121.6 | 139.31 | 169.07 | 137.84 | 148.04 | 127.12 | Upgrade |
Depreciation & Amortization | 40.61 | 40.61 | 37.56 | 33.12 | 23.76 | 21.41 | Upgrade |
Other Amortization | 0.56 | 0.56 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -0.14 | -0.14 | -0.06 | -0.27 | 0 | - | Upgrade |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.34 | 5.66 | 4.22 | 3.52 | Upgrade |
Loss (Gain) From Sale of Investments | -1.26 | -1.26 | -1.11 | -0.42 | - | -0.44 | Upgrade |
Provision & Write-off of Bad Debts | 1.26 | 1.26 | 0.14 | 0.37 | 1 | 0.9 | Upgrade |
Other Operating Activities | 51.47 | -11.59 | -9.8 | -15.11 | -0.41 | 0.53 | Upgrade |
Change in Accounts Receivable | -52.14 | -52.14 | -8.93 | -22.86 | -10.4 | -23.47 | Upgrade |
Change in Inventory | 6.4 | 6.4 | 16.92 | -41 | -31.59 | 2.36 | Upgrade |
Change in Accounts Payable | 4.31 | 4.31 | -10.19 | 55.82 | 34.21 | 17.19 | Upgrade |
Operating Cash Flow | 173 | 127.65 | 193.85 | 152.91 | 169.15 | 150 | Upgrade |
Operating Cash Flow Growth | 13.64% | -34.15% | 26.78% | -9.60% | 12.77% | 23.60% | Upgrade |
Capital Expenditures | -74.96 | -94.92 | -96.52 | -51.54 | -124.55 | -33.97 | Upgrade |
Sale of Property, Plant & Equipment | 0.29 | 0.28 | 0.25 | 0.61 | 0 | - | Upgrade |
Cash Acquisitions | -58.41 | - | - | - | - | - | Upgrade |
Divestitures | - | - | 0.09 | 0.08 | - | - | Upgrade |
Other Investing Activities | 15.91 | 14.75 | 15.5 | 8.91 | 1.71 | 1.51 | Upgrade |
Investing Cash Flow | -117.17 | -79.89 | -80.68 | -41.95 | -122.83 | -32.46 | Upgrade |
Long-Term Debt Repaid | - | -2.18 | -1.37 | -2.62 | -1.29 | - | Upgrade |
Net Debt Issued (Repaid) | -2.18 | -2.18 | -1.37 | -2.62 | -1.29 | - | Upgrade |
Issuance of Common Stock | - | - | - | 616.06 | - | - | Upgrade |
Repurchase of Common Stock | -0.61 | -0.61 | -38.25 | - | - | - | Upgrade |
Common Dividends Paid | -45.94 | -47.23 | -38.4 | -32 | -14.4 | -23.52 | Upgrade |
Other Financing Activities | -25.54 | - | - | -13.56 | - | - | Upgrade |
Financing Cash Flow | -74.26 | -50.02 | -78.02 | 567.87 | -15.69 | -23.52 | Upgrade |
Foreign Exchange Rate Adjustments | 0.16 | 1.26 | 0.79 | 6.67 | -1.15 | -1.27 | Upgrade |
Net Cash Flow | -18.27 | -1 | 35.95 | 685.5 | 29.48 | 92.75 | Upgrade |
Free Cash Flow | 98.04 | 32.73 | 97.33 | 101.36 | 44.6 | 116.03 | Upgrade |
Free Cash Flow Growth | 27.11% | -66.37% | -3.98% | 127.25% | -61.56% | 14.65% | Upgrade |
Free Cash Flow Margin | 11.67% | 4.08% | 11.17% | 13.98% | 6.74% | 20.06% | Upgrade |
Free Cash Flow Per Share | 1.56 | 0.51 | 1.52 | 1.62 | 0.93 | 2.42 | Upgrade |
Cash Income Tax Paid | 58.38 | 58.8 | 64.38 | 41.51 | 55.42 | 46.76 | Upgrade |
Levered Free Cash Flow | 35.5 | -5.71 | 50.33 | 52.33 | 14.38 | 53.02 | Upgrade |
Unlevered Free Cash Flow | 35.58 | -5.66 | 50.39 | 52.41 | 14.48 | 53.02 | Upgrade |
Change in Working Capital | -41.11 | -41.11 | -2.28 | -8.29 | -7.45 | -3.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.